Blood cancer patients are dying while potentially life-saving drugs sit on the shelf
A national blood cancer charity today launches a unique network of clinical trial centres with access to up to £50 million worth of new life-saving drugs, in response to current poor survival rates for many types of leukaemia, lymphoma and myeloma, the hub of which will be Birmingham.